BVF Inc
- SEC CIK
- 0001056807
- 最新申報
- 2026/8/14
2021 年第 2 季持倉
持倉截至 2021/6/30，2021/8/16 申報。只含多頭部位，變化是跟 2021 年第 1 季比股數。
- 持股檔數
- 70
- 較 2021 年第 1 季 +3
- 總值
- $26.7 億
- 較 2021 年第 1 季 +$92.0 萬 (0.0%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| GHRSGH Research PLC | ORDINARY SHARES | 9,275,156 | $2.02 億 | 7.6% | +9,275,156 | 新進 | 歷史 |
| ARGXArgenx SE | SPONSORED ADR | 651,204 | $1.96 億 | 7.3% | +341,605+110.3% | 加碼 | 歷史 |
| OLMAOlema Pharmaceuticals, Inc. | COM | 6,661,503 | $1.86 億 | 7.0% | 00.0% | 不變 | 歷史 |
| PTGXProtagonist Therapeutics, Inc | COM | 3,754,095 | $1.68 億 | 6.3% | −205,356−5.2% | 減碼 | 歷史 |
| MRUSMerus N.V. | COM | 7,285,071 | $1.53 億 | 5.8% | 00.0% | 不變 | 歷史 |
| KYMRKymera Therapeutics, Inc. | COM | 2,630,658 | $1.28 億 | 4.8% | 00.0% | 不變 | 歷史 |
| XOMAXOMA Royalty Corp | COM NEW | 3,530,543 | $1.20 億 | 4.5% | 00.0% | 不變 | 歷史 |
| RPTXRepare Therapeutics Inc. | COM | 3,722,398 | $1.16 億 | 4.3% | 00.0% | 不變 | 歷史 |
| RLAYRelay Therapeutics, Inc. | COM | 2,938,202 | $1.08 億 | 4.0% | +65,055+2.3% | 加碼 | 歷史 |
| RVMDRevolution Medicines, Inc. | COM | 2,485,049 | $7,888 萬 | 3.0% | −458,000−15.6% | 減碼 | 歷史 |
| RCUSArcus Biosciences, Inc. | COM | 2,797,822 | $7,683 萬 | 2.9% | +921,700+49.1% | 加碼 | 歷史 |
| EPIXESSA Pharma Inc. | COM NEW | 2,451,561 | $7,004 萬 | 2.6% | −456,765−15.7% | 減碼 | 歷史 |
| ACIUAC Immune SA | SHS | 8,545,179 | $6,776 萬 | 2.5% | +1,040,600+13.9% | 加碼 | 歷史 |
| FDMT4D Molecular Therapeutics, Inc. | COM | 2,005,862 | $4,830 萬 | 1.8% | +974,792+94.5% | 加碼 | 歷史 |
| VSTMVerastem, Inc. | COM | 11,286,258 | $4,594 萬 | 1.7% | −194,736−1.7% | 減碼 | 歷史 |
| SNDXSyndax Pharmaceuticals Inc | COM | 2,486,429 | $4,269 萬 | 1.6% | +2,322,905+1,420.5% | 加碼 | 歷史 |
| LXRXLexicon Pharmaceuticals, Inc. | COM NEW | 8,394,000 | $3,853 萬 | 1.4% | 00.0% | 不變 | 歷史 |
| REPLReplimune Group, Inc. | COM | 918,928 | $3,531 萬 | 1.3% | +457,500+99.1% | 加碼 | 歷史 |
| VIRXViracta Therapeutics, Inc. | COM | 3,094,174 | $3,509 萬 | 1.3% | 00.0% | 不變 | 歷史 |
| KURAKura Oncology, Inc. | COM | 1,635,112 | $3,409 萬 | 1.3% | 00.0% | 不變 | 歷史 |
| Rain Oncology Inc.75082Q105 | COM | 1,945,949 | $3,024 萬 | 1.1% | +1,945,949 | 新進 | – |
| SPROSpero Therapeutics, Inc. | COM | 2,137,978 | $2,985 萬 | 1.1% | 00.0% | 不變 | 歷史 |
| JANXJanux Therapeutics, Inc. | COM | 1,176,681 | $2,936 萬 | 1.1% | +1,176,681 | 新進 | 歷史 |
| XENEXenon Pharmaceuticals Inc. | COM | 1,571,778 | $2,927 萬 | 1.1% | −1,910,000−54.9% | 減碼 | 歷史 |
| Therapeutics Acquisition Cor88339T103 | COM CL A | 2,772,226 | $2,850 萬 | 1.1% | +2,000,000+259.0% | 加碼 | – |
| OVIDOvid Therapeutics Inc. | COM | 6,631,051 | $2,593 萬 | 1.0% | +213,500+3.3% | 加碼 | 歷史 |
| INFIInfinity Pharmaceuticals, Inc. | COM | 8,383,645 | $2,507 萬 | 0.9% | 00.0% | 不變 | 歷史 |
| IMAImageneBio, Inc. | COM | 1,767,399 | $2,481 萬 | 0.9% | +167,741+10.5% | 加碼 | 歷史 |
| MTEMMolecular Templates, Inc. | COM | 2,856,599 | $2,234 萬 | 0.8% | −7,700−0.3% | 減碼 | 歷史 |
| CTICCti Biopharma Corp | COM | 8,929,690 | $2,232 萬 | 0.8% | +2,000,000+28.9% | 加碼 | 歷史 |
| CBIOCrescent Biopharma, Inc. | COM | 9,544,262 | $2,214 萬 | 0.8% | 00.0% | 不變 | 歷史 |
| Calliditas Therapeutics AB13124Q106 | SPONSERED ADS | 750,000 | $2,208 萬 | 0.8% | 00.0% | 不變 | – |
| ELEVElevation Acquisition Group Inc. | COM | 1,590,291 | $2,158 萬 | 0.8% | +1,590,291 | 新進 | 歷史 |
| ANABAnaptysbio, Inc | COM | 808,710 | $2,097 萬 | 0.8% | −380,790−32.0% | 減碼 | 歷史 |
| DAWNDay One Biopharmaceuticals, Inc. | Stock | 918,975 | $2,093 萬 | 0.8% | +918,975 | 新進 | 歷史 |
| Pieris Pharmaceuticals Inc720795103 | COM | 5,328,239 | $2,041 萬 | 0.8% | −166,343−3.0% | 減碼 | – |
| FBRXForte Biosciences, Inc. | COM | 591,811 | $1,990 萬 | 0.7% | −126,977−17.7% | 減碼 | 歷史 |
| CGEMCullinan Therapeutics, Inc. | COM | 735,106 | $1,893 萬 | 0.7% | −314,250−29.9% | 減碼 | 歷史 |
| NGMNGM Biopharmaceuticals Inc | COM | 955,000 | $1,883 萬 | 0.7% | +955,000 | 新進 | 歷史 |
| ACRSAclaris Therapeutics, Inc. | COM | 1,000,000 | $1,756 萬 | 0.7% | +1,000,000 | 新進 | 歷史 |
| CFRXCONTRAFECT Corp | COM NEW | 3,972,300 | $1,748 萬 | 0.7% | +160,000+4.2% | 加碼 | 歷史 |
| SLNSilence Therapeutics plc | ADS | 666,666 | $1,701 萬 | 0.6% | 00.0% | 不變 | 歷史 |
| GRTSGritstone bio, Inc. | COM | 1,826,494 | $1,668 萬 | 0.6% | −34,745−1.9% | 減碼 | 歷史 |
| STROSutro Biopharma, Inc. | COM | 826,825 | $1,537 萬 | 0.6% | 00.0% | 不變 | 歷史 |
| CALACalithera Biosciences, Inc. | COM | 7,299,331 | $1,526 萬 | 0.6% | +1,732,641+31.1% | 加碼 | 歷史 |
| ELTXElicio Therapeutics, Inc. | COM | 1,036,500 | $1,350 萬 | 0.5% | +161,500+18.5% | 加碼 | 歷史 |
| IMVTImmunovant, Inc. | COM | 1,273,516 | $1,346 萬 | 0.5% | +129,500+11.3% | 加碼 | 歷史 |
| COGTCogent Biosciences, Inc. | COM | 1,532,282 | $1,243 萬 | 0.5% | 00.0% | 不變 | 歷史 |
| LITSLite Strategy, Inc. | COM NEW | 3,532,057 | $1,007 萬 | 0.4% | −56,098−1.6% | 減碼 | 歷史 |
| CRVSCorvus Pharmaceuticals, Inc. | COM | 3,678,626 | $982.2 萬 | 0.4% | +449,200+13.9% | 加碼 | 歷史 |
| GNCAGenocea Biosciences, Inc. | COM NEW | 4,012,404 | $938.9 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| ELDNEledon Pharmaceuticals, Inc. | COM | 1,113,435 | $880.7 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| CDTXCidara Therapeutics, Inc. | COM | 4,346,904 | $878.1 萬 | 0.3% | +607,200+16.2% | 加碼 | 歷史 |
| AMRNAmarin Corp PLC | SPONS ADR NEW | 1,715,981 | $751.6 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| RNACCartesian Therapeutics, Inc. | COM | 1,693,456 | $707.9 萬 | 0.3% | −686,530−28.8% | 減碼 | 歷史 |
| RNTXRein Therapeutics, Inc. | COM | 5,265,555 | $658.2 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| VRDNViridian Therapeutics, Inc. | COM | 350,081 | $640.3 萬 | 0.2% | −113,423−24.5% | 減碼 | 歷史 |
| Erytech Pharma29604W108 | SPONSORED ADR | 1,314,656 | $637.6 萬 | 0.2% | +689,656+110.3% | 加碼 | – |
| XFORX4 Pharmaceuticals, Inc | COM | 847,879 | $551.1 萬 | 0.2% | −243,700−22.3% | 減碼 | 歷史 |
| EOCNGalmed Pharmaceuticals Ltd. | SHS | 1,799,694 | $547.1 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| Eucrates Biomedical Acqu CorG3141W114 | UNIT 10/23/2027 | 500,000 | $509.5 萬 | 0.2% | 00.0% | 不變 | – |
| Frazier Lifesciences Acqu CoG3710A121 | UNIT 12/09/2025 | 500,000 | $504.0 萬 | 0.2% | 00.0% | 不變 | – |
| RACBResearch Alliance Corp. II | COM CL A | 500,000 | $500.0 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| 5 01 Acquisition Corp33836P105 | COM CL A | 500,000 | $498.5 萬 | 0.2% | 00.0% | 不變 | – |
| Forward Pharma A/S34986J204 | SPONSORD ADS NEW | 528,514 | $454.5 萬 | 0.2% | −118,785−18.4% | 減碼 | – |
| JYACJiya Acquisition Corp. | COM CL A | 300,000 | $298.2 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| RZLTRezolute, Inc. | COM NEW | 190,815 | $272.3 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| IVAInventiva S.A. | ADS | 107,000 | $145.5 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| CNTACentessa Pharmaceuticals plc | SPONSORED ADS | 58,900 | $130.8 萬 | <0.1% | +58,900 | 新進 | 歷史 |
| CRNXCrinetics Pharmaceuticals, Inc. | COM | 24,280 | $45.8 萬 | <0.1% | +24,280 | 新進 | 歷史 |
2021 年第 1 季之後清倉（6 檔）
2021 年第 1 季季末還持有、這份申報已經沒有的部位。
| 證券 | 類別 | 2021 年第 1 季股數 | 2021 年第 1 季市值 | 2021 年第 1 季佔組合 % | 紀錄 |
|---|---|---|---|---|---|
| Five Prime Therapeutics Inc33830X104 | COM | 6,338,678 | $2.39 億 | 9.0% | – |
| IONSIonis Pharmaceuticals Inc | COM | 1,364,461 | $6,135 萬 | 2.3% | 歷史 |
| IDYAIDEAYA Biosciences, Inc. | COM | 2,607,969 | $6,129 萬 | 2.3% | 歷史 |
| CTMXCytomX Therapeutics, Inc. | COM | 5,576,471 | $4,311 萬 | 1.6% | 歷史 |
| BCTG Acquisition Corp05492W103 | COM | 800,000 | $889.6 萬 | 0.3% | – |
| SNCEScience 37 Holdings, Inc. | COM | 100,000 | $101.4 萬 | <0.1% | 歷史 |